765 related articles for article (PubMed ID: 18990014)
41. Impact of management on the prognosis of pure uterine papillary serous cancer - a Taiwanese Gynecologic Oncology Group (TGOG) study.
Huang CY; Tang YH; Chiang YC; Wang KL; Fu HC; Ke YM; Lau HY; Hsu KF; Wu CH; Cheng WF
Gynecol Oncol; 2014 May; 133(2):221-8. PubMed ID: 24556064
[TBL] [Abstract][Full Text] [Related]
42. The role of surgery and treatment trends in uterine sarcoma.
Benoit L; Arnould L; Cheynel N; Goui S; Collin F; Fraisse J; Cuisenier J
Eur J Surg Oncol; 2005 May; 31(4):434-42. PubMed ID: 15837053
[TBL] [Abstract][Full Text] [Related]
43. Low-grade and high-grade endometrial stromal sarcoma: A National Cancer Database study.
Seagle BL; Shilpi A; Buchanan S; Goodman C; Shahabi S
Gynecol Oncol; 2017 Aug; 146(2):254-262. PubMed ID: 28596015
[TBL] [Abstract][Full Text] [Related]
44. Limitations of adjuvant radiotherapy for uterine sarcomas spread beyond the uterus.
Dusenbery KE; Potish RA; Judson P
Gynecol Oncol; 2004 Jul; 94(1):191-6. PubMed ID: 15262141
[TBL] [Abstract][Full Text] [Related]
45. Treatment and recurrence patterns in endometrial stromal sarcomas and the relation to c-kit expression.
Geller MA; Argenta P; Bradley W; Dusenbery KE; Brooker D; Downs LS; Judson PL; Carson LF; Boente MP
Gynecol Oncol; 2004 Dec; 95(3):632-6. PubMed ID: 15581975
[TBL] [Abstract][Full Text] [Related]
46. Prognostic factors, treatment and outcome in a Turkish population with endometrial stromal sarcoma.
Donertas A; Nayki U; Nayki C; Ulug P; Gultekin E; Yildirim Y
Asian Pac J Cancer Prev; 2015; 16(3):881-7. PubMed ID: 25735377
[TBL] [Abstract][Full Text] [Related]
47. Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri.
Knocke TH; Kucera H; Dörfler D; Pokrajac B; Pötter R
Cancer; 1998 Nov; 83(9):1972-9. PubMed ID: 9806656
[TBL] [Abstract][Full Text] [Related]
48. Uterine sarcoma in the south of Israel: study of 36 cases.
Piura B; Rabinovich A; Yanai-Inbar I; Cohen Y; Glezerman M
J Surg Oncol; 1997 Jan; 64(1):55-62. PubMed ID: 9040802
[TBL] [Abstract][Full Text] [Related]
49. [Postoperative radiotherapy of uterine sarcoma: a multicentric retrospective study].
Champetier C; Hannoun-Levi JM; Resbeut M; Azria D; Salem N; Tessier E; Ellis S; Cowen D;
Cancer Radiother; 2011 Apr; 15(2):89-96. PubMed ID: 20674447
[TBL] [Abstract][Full Text] [Related]
50. Endometrial stromal sarcoma-A retropsective analysis of factors affecting recurrence.
Agarwal R; Rajanbabu A; Nair IR; Satish C; Jose G; Unikrishnan UG
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():92-97. PubMed ID: 28738297
[TBL] [Abstract][Full Text] [Related]
51. Uterine sarcomas: a review of the Edinburgh experience from 1974 to 1992.
Tinkler SD; Cowie VJ
Br J Radiol; 1993 Nov; 66(791):998-1001. PubMed ID: 8281393
[TBL] [Abstract][Full Text] [Related]
52. Systemic treatment in adult uterine sarcomas.
Desar IME; Ottevanger PB; Benson C; van der Graaf WTA
Crit Rev Oncol Hematol; 2018 Feb; 122():10-20. PubMed ID: 29458779
[TBL] [Abstract][Full Text] [Related]
53. Impact of radiotherapy on local control and survival in uterine sarcomas: a retrospective study from the Grup Oncologic Català-Occità.
Ferrer F; Sabater S; Farrús B; Guedea F; Rovirosa A; Anglada L; Delannes M; Marín S; DuBois JB; Daly-Schveitzer N
Int J Radiat Oncol Biol Phys; 1999 Apr; 44(1):47-52. PubMed ID: 10219793
[TBL] [Abstract][Full Text] [Related]
54. Uterine adenosarcoma with sarcomatous overgrowth versus uterine carcinosarcoma: comparison of treatment and survival.
Krivak TC; Seidman JD; McBroom JW; MacKoul PJ; Aye LM; Rose GS
Gynecol Oncol; 2001 Oct; 83(1):89-94. PubMed ID: 11585418
[TBL] [Abstract][Full Text] [Related]
55. Uterine Sarcomas: The Latest Approaches for These Rare but Potentially Deadly Tumors.
Chern JY; Boyd LR; Blank SV
Oncology (Williston Park); 2017 Mar; 31(3):229-36. PubMed ID: 28299760
[TBL] [Abstract][Full Text] [Related]
56. Prognostic features of sarcomas and mixed tumors of the endometrium.
Peters WA; Kumar NB; Fleming WP; Morley GW
Obstet Gynecol; 1984 Apr; 63(4):550-6. PubMed ID: 6322081
[TBL] [Abstract][Full Text] [Related]
57. The role of adjuvant radiation in uterine sarcomas.
Sampath S; Schultheiss TE; Ryu JK; Wong JY
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):728-34. PubMed ID: 19700247
[TBL] [Abstract][Full Text] [Related]
58. Uterine sarcoma: a clinicopathological study of 93 cases.
González-Bosquet E; Martínez-Palones JM; González-Bosquet J; García Jiménez A; Xercavins J
Eur J Gynaecol Oncol; 1997; 18(3):192-5. PubMed ID: 9174834
[TBL] [Abstract][Full Text] [Related]
59. Outcome and prognostic factors in endometrial stromal tumors: a Rare Cancer Network study.
Schick U; Bolukbasi Y; Thariat J; Abdah-Bortnyak R; Kuten A; Igdem S; Caglar H; Ozsaran Z; Lössl K; Schleicher U; Zwahlen D; Villette S; Vees H
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):e757-63. PubMed ID: 22300565
[TBL] [Abstract][Full Text] [Related]
60. Malignant mixed Mullerian tumours of the uterus--a ten-year experience.
Ho SP; Ho TH
Singapore Med J; 2002 Sep; 43(9):452-6. PubMed ID: 12568422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]